Vitamin C and Cancer: The Role of Vitamin C in Disease Progression and Quality of Life in Cancer Patients

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
   Google Scholar
• Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault M-C. Vitamin C supplement intake and postmenopausal breast cancer risk: Interaction with dietary vitamin C. Am J Clin Nutr. 2016;104(1):228–34. doi:10.3945/ajcn.115.126326
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Association between intake of antioxidants and pancreatic cancer risk: A meta-analysis. Int J Food Sci Nutr. 2016;67(7):744–53. doi:10.1080/09637486.2016.1197892
   PubMed Web of Science ®Google Scholar
• Cao D, Shen K, Li Z, Xu Y, Wu D. Association between vitamin C Intake and the risk of cervical neoplasia: A meta-analysis. Nutr Cancer. 2016;68(1):48–57. doi:10.1080/01635581.2016.1115101
   PubMed Web of Science ®Google Scholar
• Jia L, Jia Q, Shang Y, Dong X, Li L. Vitamin C intake and risk of renal cell carcinoma: A meta-analysis. Sci Rep. 2015;5:17921. doi:10.1038/srep17921
   PubMed Web of Science ®Google Scholar
• Bo Y, Lu Y, Zhao Y, Zhao E, Yuan L, Lu W, Cui L, Lu Q. Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis. Int J Cancer. 2016;138(8):1843–50. doi:10.1002/ijc.29838
   PubMed Web of Science ®Google Scholar
• Bai X-Y, Qu X, Jiang X, Xu Z, Yang Y, Su Q, Wang M, Wu H. Association between dietary vitamin C intake and risk of prostate cancer: A meta-analysis involving 103,658 subjects. J Cancer. 2015;6(9):913–21. doi:10.7150/jca.12162
   PubMed Web of Science ®Google Scholar
• Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L, Beuth J. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 2011;25(6):983–90.
   PubMed Web of Science ®Google Scholar
• Mayland CR, Bennett MI, Allan K. Vitamin C deficiency in cancer patients. Palliat Med. 2005;19(1):17–20. doi:10.1191/0269216305pm970oa
   PubMed Web of Science ®Google Scholar
• Mahdavi R, Faramarzi E, Seyedrezazadeh E, Mohammad- Zadeh M, Pourmoghaddam M. Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients. Biol Trace Elem Res. 2009;130(1):1–6. doi:10.1007/s12011-008-8309-2
   PubMed Web of Science ®Google Scholar
• Mikirova N, Casciari J, Riordan N, Hunninghake R. Clinical experience with intravenous administration of ascorbic acid: Achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med. 2013;11:191. doi:10.1186/1479-5876-11-191
   PubMed Web of Science ®Google Scholar
• Alexandrescu DT, Dasanu CA, Kauffman CL. Acute scurvy during treatment with interleukin-2. Clin Exp Dermatol. 2009;34(7):811–4. doi:10.1111/j.1365-2230.2008.03052.x
   PubMed Web of Science ®Google Scholar
• Gupta A, Bhatt ML, Misra MK. Lipid peroxidation and antioxidant status in head and neck squamous cell carcinoma patients. Oxid Med Cell Longev. 2009;2(2):68–72. doi:10.4161/oxim.2.2.8160
   PubMed Web of Science ®Google Scholar
• Gan R, Eintracht S, Hoffer LJ. Vitamin C deficiency in a university teaching hospital. J Am Coll Nutr. 2008;27(3):428–33. doi:10.1080/07315724.2008.10719721
   PubMed Web of Science ®Google Scholar
• Fain O. Vitamin C [French]. Rev Prat. 2013;63:1091–6.
   PubMedGoogle Scholar
• Emri S, Kilickap S, Kadilar C, Halil MG, Akay H, Besler T. Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pac J Cancer Prev. 2012;13(7):3025–9. doi:10.7314/APJCP.2012.13.7.3025
   PubMedGoogle Scholar
• Mehdi WA, Zainulabdeen JA, Mehde AA. Investigation of the antioxidant status in multiple myeloma patients: Effects of therapy. Asian Pac J Cancer Prev. 2013;14(6):3663–7. doi:10.7314/apjcp.2013.14.6.3663
   PubMedGoogle Scholar
• Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007;22(1):7–11. doi:10.3346/jkms.2007.22.1.7
   PubMed Web of Science ®Google Scholar
• Carr AC, Vissers MD, Cook JS. The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life. Front Oncol. 2014;4:283. doi:10.3389/fonc.2014.00283
   PubMedGoogle Scholar
• Takahashi H, Mizuno H, Yanagisawa A. High-dose intravenous vitamin C improves quality of life in cancer patients. Personalized Medicine Universe. 2012;1(1):49–53. doi:10.1016/j.pmu.2012.05.008
   Google Scholar
• Mikirova N, Casciari J, Rogers A, Taylor P. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med. 2012;10:189. doi:10.1186/1479-5876-10-189
   PubMed Web of Science ®Google Scholar
• Esme H, Cemek M, Sezer M, Saglam H, Demir A, Melek H, Unlu M. High levels of oxidative stress in patients with advanced lung cancer. Respirology. 2008;13(1):112–6. doi:10.1111/j.1440-1843.2007.01212.x
   PubMed Web of Science ®Google Scholar
• Yalcin O, Karatas F, Erulas FA, Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int. 2004;93(6):863–6.
   PubMed Web of Science ®Google Scholar
• Akinloye O, Adaramoye O, Kareem O. Changes in antioxidant status and lipid peroxidation in Nigerian patients with prostate carcinoma. Pol Arch Med Wewn. 2009;119(9):526–32. doi:10.20452/pamw.759
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA. 2008;105(32):11105–9. doi:10.1073/pnas.0804226105
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a prodrug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 2005;102(38):13604–9. doi:10.1073/pnas.0506390102
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Lee J-H, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA. 2007;104(21):8749–54. doi:10.1073/pnas.0702854104
   PubMed Web of Science ®Google Scholar
• Lee SJ, Jeong J-H, Lee IH, Lee J, Jung JH, Park HY, Lee DH, Chae YS. Effect of high-dose vitamin C combined with anti-cancer treatment on breast cancer cells. Anticancer Res. 2019;39(2):751–8. doi:10.21873/anticanres.13172
   PubMed Web of Science ®Google Scholar
• Welsh JL, Wagner BA, van’t Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts LJ, et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trial. Cancer Chemother Pharmacol. 2013;71(3):765–75. doi:10.1007/s00280-013-2070-8
   PubMed Web of Science ®Google Scholar
• Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, Miller WH. Phase I clinical trial of I.V. ascorbic acid in advanced malignancy. Ann Oncol. 2008;19(11):1969–74. [Erratum in: Ann Oncol 2008;19:2095]. doi:10.1093/annonc/mdn377
   PubMed Web of Science ®Google Scholar
• Stephenson CM, Levin RD, Spector T, Lis CG. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol. 2013;72(1):139–46. doi:10.1007/s00280-013-2179-9
   PubMed Web of Science ®Google Scholar
• Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014;6(222):222ra18. doi:10.1126/scitranslmed.3007154
   PubMed Web of Science ®Google Scholar
• Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S, Levine M, et al. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One. 2012;7(1):e29794. doi:10.1371/journal.pone.0029794
   PubMed Web of Science ®Google Scholar
• Cui Y, Shikany JM, Liu S, Shagufta Y, Rohan TE. Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am J Clin Nutr. 2008;87(4):1009–18. doi:10.1093/ajcn/87.4.1009
   PubMed Web of Science ®Google Scholar
• Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson JE, Hankinson SE, Willett WC. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst. 1999;91(6):547–56. doi:10.1093/jnci/91.6.547
   PubMedGoogle Scholar
• Roswall N, Olsen A, Christensen J, Dragsted LO, Overvad K, et al. Micronutrient intake and breast cancer characteristics among postmenopausal women. Eur J Cancer Prev. 2010;19:360–5.
   PubMed Web of Science ®Google Scholar
• Rohan TE, Howe GR, Friedenreich CM, Jain M, Miller AB. Dietary fiber, vitamins A, C, and E, and risk of breast cancer: A cohort study. Cancer Causes Control. 1993;4(1):29–37. doi:10.1007/BF00051711
   PubMed Web of Science ®Google Scholar
• Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996;144(2):165–74. doi:10.1093/oxfordjournals.aje.a008904
   PubMed Web of Science ®Google Scholar
• Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, Buring JE, Manson JE. Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trial. J Natl Cancer Inst. 2009;101(1):14–23. doi:10.1093/jnci/djn438
   PubMed Web of Science ®Google Scholar
• Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974;9(4):285–315. doi:10.1016/0009-2797(74)90019-2
   PubMed Web of Science ®Google Scholar
• Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 1976;73(10):3685–9. doi:10.1073/pnas.73.10.3685
   PubMed Web of Science ®Google Scholar
• Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 1978;75(9):4538–42. doi:10.1073/pnas.75.9.4538
   PubMed Web of Science ®Google Scholar
• Benade L, Howard T, Burk D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole. Oncology. 1969;23(1):33–43. doi:10.1159/000224465
   PubMed Web of Science ®Google Scholar
• Bram S, Froussard P, Guichard M, Jasmin C, Augery Y, Sinoussi-Barre F, Wray W. Vitamin C preferential toxicity for malignant melanoma cells. Nature. 1980;284(5757):629–31. doi:10.1038/284629a0
   PubMed Web of Science ®Google Scholar
• Leung PY, Miyashita K, Young M, Tsao CS. Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res. 1993;13(2):475–80.
   PubMed Web of Science ®Google Scholar
• Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer. 2001;84(11):1544–50. doi:10.1054/bjoc.2001.1814
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102(38):13604–9.
   PubMed Web of Science ®Google Scholar
• Sullivan GG, Chen Q, Chen P, Chapman J, Levine M, et al. Prospective randomized phase I/IIa pilot trial to assess safety and benefit administering high-dose intravenous ascorbate in combination with chemotherapy in newly diagnosed advanced stage III or Stage IV ovarian cancer. Conference abstract of the Society of Integrative Oncology; 2011 November; Cleveland, OH.
   Google Scholar
• Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A, et al. Intravenous vitamin C as a chemotherapy agent: A report on clinical cases. P R Health Sci J. 2004;23(2):115–8.
   PubMedGoogle Scholar
• Abdel-Latif MM, Raouf AA, Sabra K, Kelleher D, Reynolds JV. Vitamin C enhances chemosensitization of esophageal cancer cells in vitro. J Chemother. 2005;17(5):539–49. doi:10.1179/joc.2005.17.5.539
   PubMed Web of Science ®Google Scholar
• Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett. 1996;103(2):183–9. doi:10.1016/0304-3835(96)04212-7
   PubMed Web of Science ®Google Scholar
• Prasad KN, Sinha PK, Ramanujam M, Sakamoto A. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA. 1979;76(2):829–32. doi:10.1073/pnas.76.2.829
   PubMed Web of Science ®Google Scholar
• Reddy VG, Khanna N, Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem Biophys Res Commun. 2001;282(2):409–15. doi:10.1006/bbrc.2001.4593
   PubMed Web of Science ®Google Scholar
• Taper HS, de Gerlache J, Lans M, Roberfroid M. Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int J Cancer. 1987;40(4):575–9. doi:10.1002/ijc.2910400424
   PubMed Web of Science ®Google Scholar
• Wells WW, Rocque PA, Xu DP, Meyer EB, Charamella LJ, Dimitrov NV. Ascorbic acid and cell survival of Adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Radic Biol Med. 1995;18(4):699–708. doi:10.1016/0891-5849(94)00188-p
   PubMed Web of Science ®Google Scholar
• Verrax J, Calderon PB. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med. 2009;47(1):32–40. doi:10.1016/j.freeradbiomed.2009.02.016
   PubMed Web of Science ®Google Scholar
• Frömberg A, Gutsch D, Schulze D, Vollbracht C, Weiss G, Czubayko F, Aigner A. Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs. Cancer Chemother Pharmacol. 2011;67(5):1157–66. doi:10.1007/s00280-010-1418-6
   PubMed Web of Science ®Google Scholar
• Martinotti S, Ranzato E, Burlando B. In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma. Toxicol In Vitro. 2011;25(8):1568–74. doi:10.1016/j.tiv.2011.05.023
   PubMed Web of Science ®Google Scholar
• Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M, Chen Q. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med. 2011;50(11):1610–9. doi:10.1016/j.freeradbiomed.2011.03.007
   PubMed Web of Science ®Google Scholar
• Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer. 1994;22(3):233–45. doi:10.1080/01635589409514349
   PubMed Web of Science ®Google Scholar
• Pathak AK, Singh N, Khanna N, Reddy VG, Prasad KN, Kochupillai V. Potentiation of the effect of paclitaxel and carboplatin by antioxidant mixture on human lung cancer h520 cells. J Am Coll Nutr. 2002;21(5):416–21. doi:10.1080/07315724.2002.10719244
   PubMed Web of Science ®Google Scholar
• Bannerman B, Xu L, Jones M, Tsu C, Yu J, Hales P, Monbaliu J, Fleming P, Dick L, Manfredi M, et al. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea. Cancer Chemother Pharmacol. 2011;68(5):1145–54. doi:10.1007/s00280-011-1591-2
   PubMed Web of Science ®Google Scholar
• Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G, Santo L, Cirstea D, Raje N, Chauhan D, et al. Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia. 2009;23(9):1679–86. doi:10.1038/leu.2009.83
   PubMed Web of Science ®Google Scholar
• Chen AA, Marsit CJ, Christensen BC, Houseman EA, McClean MD, Smith JF, Bryan JT, Posner MR, Nelson HH, Kelsey KT, et al. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis. 2009;30(6):977–81. doi:10.1093/carcin/bgp076
   PubMed Web of Science ®Google Scholar
• Erichsen HC, Peters U, Eck P, Welch R, Schoen RE, Yeager M, Levine M, Hayes RB, Chanock S. Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr Cancer. 2008;60(5):652–9. doi:10.1080/01635580802033110
   PubMed Web of Science ®Google Scholar
• Wright ME, Andreotti G, Lissowska J, Yeager M, Zatonski W, Chanock SJ, Chow W-H, Hou L. Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer. 2009;45(10):1824–30. doi:10.1016/j.ejca.2009.01.027
   PubMed Web of Science ®Google Scholar
• Park J-H, Davis KR, Lee G, Jung M, Jung Y, Park J, Yi S-Y, Lee M-A, Lee S, Yeom C-H, et al. Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice. Nutr Res. 2012;32(11):873–83. doi:10.1016/j.nutres.2012.09.011
   PubMed Web of Science ®Google Scholar
• An SH, Kang JH, Kim DH, Lee MS. Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells. BMB Rep. 2011;44(3):211–6. doi:10.5483/BMBRep.2011.44.3.211
   PubMed Web of Science ®Google Scholar
• Levine M, Padayatty SJ, Espey MG. Vitamin C: A concentration- function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011;2(2):78–88. doi:10.3945/an.110.000109
   PubMed Web of Science ®Google Scholar
• Kimoto E, Tanaka H, Gyotoku J, Morishige F, Pauling L. Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex. Cancer Res. 1983;43(2):824–8.
   PubMed Web of Science ®Google Scholar
• Ranzato E, Biffo S, Burlando B. Selective ascorbate toxicity in malignant mesothelioma: A redox Trojan mechanism. Am J Respir Cell Mol Biol. 2011;44(1):108–17. doi:10.1165/rcmb.2009-0340OC
   PubMed Web of Science ®Google Scholar
• Maramag C, Menon M, Balaji KC, Reddy PG, Laxmanan S. Effect of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis. Prostate. 1997;32(3):188–95. doi:10.1002/(SICI)1097-0045(19970801)32:3<188::AID-PROS5>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Hong S-W, Lee S-H, Moon J-H, Hwang JJ, Kim DE, Ko E, Kim H-S, Cho IJ, Kang JS, Kim DJ, et al. SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment. Oncogene. 2013;32(12):1508–17. doi:10.1038/onc.2012.176
   PubMed Web of Science ®Google Scholar
• Hong S-W, Jin D-H, Hahm E-S, Yim S-H, Lim J-S, Kim K-I, Yang Y, Lee S-S, Kang J-S, Lee W-J, et al. Ascorbate (vitamin C) induces cell death through the apoptosis-inducing factor in human breast cancer cells. Oncol Rep. 2007;18(4):811–5. doi:10.3892/or.18.4.811
   PubMed Web of Science ®Google Scholar
• Bhat SH, Azmi AS, Hanif S, Hadi SM. Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties. Int J Biochem Cell Biol. 2006;38(12):2074–81. doi:10.1016/j.biocel.2006.05.017
   PubMed Web of Science ®Google Scholar
• Park S, Han S-S, Park CH, Hahm E-R, Lee SJ, Park HK, Lee S-H, Kim WS, Jung CW, Park K, et al. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms. Int J Biochem Cell Biol. 2004;36(11):2180–95. doi:10.1016/j.biocel.2004.04.005
   PubMed Web of Science ®Google Scholar
• Vuyyuri SB, Rinkinen J, Worden E, Shim H, Lee S, Davis KR. Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cells. PLoS One. 2013;8(6):e67081. doi:10.1371/journal.pone.0067081
   PubMed Web of Science ®Google Scholar
• Chen P, Yu J, Chalmers B, Drisko J, Yang J, Li B, Chen Q. Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anticancer Drugs. 2012;23(4):437–44. doi:10.1097/CAD.0b013e32834fd01f
   PubMed Web of Science ®Google Scholar
• Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang S-h, Taghiyev AF, Du C, Knudson CM, Cullen JJ, et al. Mechanisms of ascorbateinduced cytotoxicity in pancreatic cancer. Clin Cancer Res. 2010;16(2):509–20. doi:10.1158/1078-0432.CCR-09-1713
   PubMed Web of Science ®Google Scholar
• Kim JE, Kang JS, Lee WJ. Vitamin C induces apoptosis in human colon cancer cell line, HCT-8 via the modulation of calcium influx in endoplasmic reticulum and the dissociation of bad from 14-3-3β. Immune Netw. 2012;12(5):189–95. doi:10.4110/in.2012.12.5.189
   PubMedGoogle Scholar
• Kuiper C, Molenaar IGM, Dachs GU, Currie MJ, Sykes PH, Vissers MCM. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Cancer Res. 2010;70(14):5749–58. doi:10.1158/0008-5472.CAN-10-0263
   PubMed Web of Science ®Google Scholar
• Kim J, Lee S-D, Chang B, Jin D-H, Jung S-I, Park M-Y, Han Y, Yang Y, Il Kim K, Lim J-S, et al. Enhanced antitumor activity of vitamin C via p53 in cancer cells. Free Radic Biol Med. 2012;53(8):1607–15. doi:10.1016/j.freeradbiomed.2012.07.079
   PubMed Web of Science ®Google Scholar
• Pollard HB, Levine MA, Eidelman O, Pollard M. Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer. In Vivo. 2010;24(3):249–55.
   PubMed Web of Science ®Google Scholar
• Kim HN, Kim H, Kong JM, Bae S, Kim YS, Lee N, Cho BJ, Lee SK, Kim H-R, Hwang Y-i, et al. Vitamin C down-regulates VEGF production in B16F10 murine melanoma cells via the suppression of p42/44 MAPK activation. J Cell Biochem. 2011;112(3):894–901. doi:10.1002/jcb.22997
   PubMed Web of Science ®Google Scholar
• Mikirova NA, Casciari JJ, Riordan NH. Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res. 2010;2:2. doi:10.1186/2040-2384-2-2
   PubMedGoogle Scholar
• Lee SK, Kang JS, Jung DJ, Hur DY, Kim JE, Hahm E, Bae S, Kim HW, Kim D, Cho BJ, et al. Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production. J Cell Physiol. 2008;216(1):180–8. doi:10.1002/jcp.21391
   PubMed Web of Science ®Google Scholar
• Yeom C-H, Lee G, Park J-H, Yu J, Park S, Yi S-Y, Lee HR, Hong YS, Yang J, Lee S, et al. High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med. 2009;7:70. doi:10.1186/1479-5876-7-70
   PubMed Web of Science ®Google Scholar
• Carcamo JM, Pedraza A, Borquez-Ojeda O, Golde DW. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry. 2002;41(43):12995–3002. doi:10.1021/bi0263210
   PubMed Web of Science ®Google Scholar
• Son EW, Mo SJ, Rhee DK, Pyo S. Vitamin C blocks TNF-α-induced NF-kB activation and ICAM-1 expression in human neuroblastoma cells . Arch Pharm Res. 2004;27(10):1073–9. doi:10.1007/BF02975434
   Web of Science ®Google Scholar
• Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol. 1997;12(2):525–35.
   PubMed Web of Science ®Google Scholar
• Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: A new paradigm for oxidative stress. IUBMB Life. 1999;48(1):41–7. doi:10.1080/713803463
   PubMed Web of Science ®Google Scholar
• Robitaille L, Mamer OA, Miller WH, Levine M, Assouline S, Melnychuk D, Rousseau C, Hoffer LJ. Oxalic acid excretion after intravenous ascorbic acid administration. Metab Clin Exp. 2009;58(2):263–9. doi:10.1016/j.metabol.2008.09.023
   PubMed Web of Science ®Google Scholar
• Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005;24(4):269–76.
   PubMedGoogle Scholar
• Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest. 1998;28(9):695–700. doi:10.1046/j.1365-2362.1998.00349.x
   PubMed Web of Science ®Google Scholar
• Mashour S, Turner JF, Jr, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: A case report and review of the literature. Chest. 2000;118(2):561–3. doi:10.1378/chest.118.2.561
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10:840–5.
   PubMed Web of Science ®Google Scholar
• Gerster H. No contribution of ascorbic acid to renal calcium oxalate stones. Ann Nutr Metab. 1997;41(5):269–82. doi:10.1159/000177954
   PubMed Web of Science ®Google Scholar
• Mehta JB, Singhal SB, Mehta BC. Ascorbic-acid-induced haemolysis in g-6-pd deficiency. Lancet. 1990;336(8720):944. doi:10.1016/0140-6736(90)92317-b
   PubMed Web of Science ®Google Scholar
• Rees DC, Kelsey H, Richards JD. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ. 1993;306(6881):841–2. doi:10.1136/bmj.306.6881.841
   PubMedGoogle Scholar
• Braunstein EM. Glucose 6-phosphate dehydrogenase deficiency. In: Lichtin AE, editors. Merck manual: professional edition. 19th ed. Kenilworth, NJ: Merck Sharp and Dohme Corp; 2018. [accessed 2016 January 8]. http://www.merckmanuals.com/professional/hematology_and_oncology/anemias_caused_by_hemolysis/glucose-6-phosphate_dehydrogenase_g6pd_deficiency.html.
   Google Scholar
• Rosenthal G. Interaction of ascorbic acid and warfarin. JAMA. 1971;215(10):1671.
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: Intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010;5(7):e11414doi:10.1371/journal.pone.0011414
   PubMed Web of Science ®Google Scholar
• Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: Combinations to avoid. Radiat Res. 1996;145(5):532–41. doi:10.2307/3579271
   PubMed Web of Science ®Google Scholar
• McCarty MF, Barroso-Aranda J, Contreras F. Oxidative stress therapy for solid tumors - a proposal. Med Hypotheses. 2010;74(6):1052–4. doi:10.1016/j.mehy.2009.12.029
   PubMed Web of Science ®Google Scholar
• Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51(3):794–8.
   PubMed Web of Science ®Google Scholar